NCT04105270
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04105270
Title RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Masonic Cancer Center, University of Minnesota
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Dr. Amit Kulkarni NOT_YET_RECRUITING Phoenix Arizona 85338 United States Details
MNCCTN Essentia Health St. Joseph's Brainerd Medical Center RECRUITING Brainerd Minnesota 56401 United States Details
MNCCTN Essentia Health Deer River RECRUITING Deer River Minnesota 56636 United States Details
MNCCTN Essentia Health St. Mary's Detroit Lakes Clinic RECRUITING Detroit Lakes Minnesota 56501 United States Details
MNCCTN Essentia Health Duluth RECRUITING Duluth Minnesota 55805 United States Details
MNCCTN Essentia Health Fosston RECRUITING Fosston Minnesota 56542 United States Details
MNCCTN Essentia Health Hibbing Clinic RECRUITING Hibbing Minnesota 55746 United States Details
Masonic Cancer Center, University of Minnesota RECRUITING Minneapolis Minnesota 55455 United States Details
MNCCTN Essentia Health Sandstone RECRUITING Sandstone Minnesota 550723 United States Details
MNCCTN Essentia Health Virginia Clinic RECRUITING Virginia Minnesota 55792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field